Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00026910 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00026910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
July 31, 1998
Completion date
May 31, 2002
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma